US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 3.2799
  • -0.1301-3.82%
Trading Oct 2 10:40 ET
16.45MMarket Cap-596P/E (TTM)

Matinas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
-65.62%1.1M
0
0
0
1.1M
9,560.61%3.19M
319,319.22%1.06M
1.06M
Operating revenue
--0
--0
-65.62%1.1M
--0
--0
--0
--1.1M
9,560.61%3.19M
319,319.22%1.06M
--1.06M
Cost of revenue
Gross profit
Operating expense
-5.20%5.84M
-11.67%5.9M
-10.50%24.86M
-10.03%5.89M
-5.99%6.13M
-11.86%6.16M
-13.47%6.68M
12.15%27.78M
-2.55%6.54M
-5.13%6.53M
Selling and administrative expenses
-5.08%2.47M
-9.44%2.46M
-6.55%10.37M
-16.97%2.22M
0.75%2.84M
-9.12%2.6M
-1.17%2.71M
8.98%11.1M
8.15%2.68M
24.87%2.82M
-General and administrative expense
-5.08%2.47M
-9.44%2.46M
-6.55%10.37M
-16.97%2.22M
0.75%2.84M
-9.12%2.6M
-1.17%2.71M
8.98%11.1M
8.15%2.68M
24.87%2.82M
Research and development costs
-5.28%3.37M
-13.20%3.45M
-13.13%14.49M
-5.22%3.67M
-11.11%3.3M
-13.76%3.56M
-20.25%3.97M
14.37%16.68M
-8.79%3.87M
-19.78%3.71M
Operating profit
5.20%-5.84M
-5.66%-5.9M
3.35%-23.77M
-7.43%-5.89M
-12.30%-6.13M
-3.95%-6.16M
27.66%-5.59M
0.59%-24.59M
18.38%-5.48M
20.59%-5.46M
Net non-operating interest income expense
Other net income (expense)
21.21%120K
6.85%78K
-77.07%824K
-68.96%573K
79K
4,850.00%99K
-95.81%73K
147.45%3.59M
12,019.22%1.85M
Special income (charges)
----
----
-86.14%484K
-72.45%484K
--0
----
----
162.88%3.49M
373,929.79%1.76M
--0
-Gain on sale of business
----
----
-86.14%484K
-72.45%484K
--0
----
----
162.88%3.49M
373,929.79%1.76M
--0
Other non- operating income (expenses)
21.21%120K
6.85%78K
233.33%340K
0.00%89K
--79K
4,850.00%99K
630.00%73K
-17.74%102K
466.81%89K
----
Income before tax
5.63%-5.72M
-5.64%-5.82M
-9.26%-22.94M
-46.23%-5.31M
-10.86%-6.06M
-2.31%-6.06M
7.78%-5.51M
9.82%-21M
45.75%-3.63M
20.11%-5.46M
Income tax
Net income
5.63%-5.72M
-5.64%-5.82M
-9.26%-22.94M
-46.23%-5.31M
-10.86%-6.06M
-2.31%-6.06M
7.78%-5.51M
9.82%-21M
45.75%-3.63M
20.11%-5.46M
Net income continuous Operations
5.63%-5.72M
-5.64%-5.82M
-9.26%-22.94M
-46.23%-5.31M
-10.86%-6.06M
-2.31%-6.06M
7.78%-5.51M
9.82%-21M
45.75%-3.63M
20.11%-5.46M
Minority interest income
Net income attributable to the parent company
5.63%-5.72M
-5.64%-5.82M
-9.26%-22.94M
-46.23%-5.31M
-10.86%-6.06M
-2.31%-6.06M
7.78%-5.51M
9.82%-21M
45.75%-3.63M
20.11%-5.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
5.63%-5.72M
-5.64%-5.82M
-9.26%-22.94M
-46.23%-5.31M
-10.86%-6.06M
-2.31%-6.06M
7.78%-5.51M
11.33%-21M
45.75%-3.63M
20.11%-5.46M
Basic earnings per share
33.33%-1
0.00%-1.5
-10.00%-5.5
-50.00%-1.5
0.00%-1.5
0.00%-1.5
0.00%-1.5
9.09%-5
33.33%-1
0.00%-1.5
Diluted earnings per share
33.33%-1
0.00%-1.5
-10.00%-5.5
-50.00%-1.5
0.00%-1.5
0.00%-1.5
0.00%-1.5
9.09%-5
33.33%-1
0.00%-1.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 00-65.62%1.1M0001.1M9,560.61%3.19M319,319.22%1.06M1.06M
Operating revenue --0--0-65.62%1.1M--0--0--0--1.1M9,560.61%3.19M319,319.22%1.06M--1.06M
Cost of revenue
Gross profit
Operating expense -5.20%5.84M-11.67%5.9M-10.50%24.86M-10.03%5.89M-5.99%6.13M-11.86%6.16M-13.47%6.68M12.15%27.78M-2.55%6.54M-5.13%6.53M
Selling and administrative expenses -5.08%2.47M-9.44%2.46M-6.55%10.37M-16.97%2.22M0.75%2.84M-9.12%2.6M-1.17%2.71M8.98%11.1M8.15%2.68M24.87%2.82M
-General and administrative expense -5.08%2.47M-9.44%2.46M-6.55%10.37M-16.97%2.22M0.75%2.84M-9.12%2.6M-1.17%2.71M8.98%11.1M8.15%2.68M24.87%2.82M
Research and development costs -5.28%3.37M-13.20%3.45M-13.13%14.49M-5.22%3.67M-11.11%3.3M-13.76%3.56M-20.25%3.97M14.37%16.68M-8.79%3.87M-19.78%3.71M
Operating profit 5.20%-5.84M-5.66%-5.9M3.35%-23.77M-7.43%-5.89M-12.30%-6.13M-3.95%-6.16M27.66%-5.59M0.59%-24.59M18.38%-5.48M20.59%-5.46M
Net non-operating interest income expense
Other net income (expense) 21.21%120K6.85%78K-77.07%824K-68.96%573K79K4,850.00%99K-95.81%73K147.45%3.59M12,019.22%1.85M
Special income (charges) ---------86.14%484K-72.45%484K--0--------162.88%3.49M373,929.79%1.76M--0
-Gain on sale of business ---------86.14%484K-72.45%484K--0--------162.88%3.49M373,929.79%1.76M--0
Other non- operating income (expenses) 21.21%120K6.85%78K233.33%340K0.00%89K--79K4,850.00%99K630.00%73K-17.74%102K466.81%89K----
Income before tax 5.63%-5.72M-5.64%-5.82M-9.26%-22.94M-46.23%-5.31M-10.86%-6.06M-2.31%-6.06M7.78%-5.51M9.82%-21M45.75%-3.63M20.11%-5.46M
Income tax
Net income 5.63%-5.72M-5.64%-5.82M-9.26%-22.94M-46.23%-5.31M-10.86%-6.06M-2.31%-6.06M7.78%-5.51M9.82%-21M45.75%-3.63M20.11%-5.46M
Net income continuous Operations 5.63%-5.72M-5.64%-5.82M-9.26%-22.94M-46.23%-5.31M-10.86%-6.06M-2.31%-6.06M7.78%-5.51M9.82%-21M45.75%-3.63M20.11%-5.46M
Minority interest income
Net income attributable to the parent company 5.63%-5.72M-5.64%-5.82M-9.26%-22.94M-46.23%-5.31M-10.86%-6.06M-2.31%-6.06M7.78%-5.51M9.82%-21M45.75%-3.63M20.11%-5.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 5.63%-5.72M-5.64%-5.82M-9.26%-22.94M-46.23%-5.31M-10.86%-6.06M-2.31%-6.06M7.78%-5.51M11.33%-21M45.75%-3.63M20.11%-5.46M
Basic earnings per share 33.33%-10.00%-1.5-10.00%-5.5-50.00%-1.50.00%-1.50.00%-1.50.00%-1.59.09%-533.33%-10.00%-1.5
Diluted earnings per share 33.33%-10.00%-1.5-10.00%-5.5-50.00%-1.50.00%-1.50.00%-1.50.00%-1.59.09%-533.33%-10.00%-1.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data